Immutrix Therapeutics, Inc.

New Filing
CIK: 0001656200·Biotechnology·DELAWARE·Filed: Jul 14, 2020
Total Offering

$15,000,000

Amount Sold

$300,000

Investors

1

First Sale

Jul 1, 2020

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Carol A. Rae
Related Person
Roy Ketel
Related Person
Brent R. Phillips
Related Person
Craig Hansen
Related Person
Stephanie Lien D'Urso
Related Person

Company

Immutrix Therapeutics, Inc.

3620 HOMESTEAD STREET

RAPID CITY, SD, 57703

(605) 721-7979

SEC Filing

0001656200-20-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Immutrix Therapeutics, Inc. Form D Filing — $15,000,000 | FilingFlow